Cannabichromevarin

Cannabichromevarin or CBCV (also known as cannabivarichromene) is one of over a 100 variants of cannabinoid chemical compounds that act on cannabinoid receptors.[1][2] CBCV is a phytocannabinoid found naturally in cannabis, and is a propyl cannabinoid and an effective anticonvulsant and used to treat brain cancer and epilepsy. The compound CBCV is within the patent US9084771 [3]

Cannabichromevarin
Names
IUPAC name
2-methyl-2-(4-methylpent-3-enyl)-7-propylchromen-5-ol
Other names
Cannabivarichromene
Identifiers
3D model (JSmol)
ChemSpider
UNII
Properties
C19H26O2
Molar mass 286.415 g·mol−1
Except where otherwise noted, data are given for materials in their standard state (at 25 °C [77 °F], 100 kPa).
Infobox references

CBC-V was first identified at the University of Nagasaki in 1975 from Marijuana from Thailand.

With a Molecular Formula: C19H26O2, and IUPAC Chemical Name of 2-methyl-2-(4-methylpent-3-enyl)-7-propylchromen-5-ol , Cannabichromevain has a molecular weight of 286.4 g/mol,[4] CBCV is not thought to be psychoactive or impairing in any way, and is believed to be safe for children and adults and is a compound found in medical marijuana.[5]

ReferencesEdit

  1. ^ "(±)-Cannabichromevarin (CRM) (CAS 41408-19-9)". www.caymanchem.com. U.S.: Cayman Chemical Company. Retrieved 2019-12-23.
  2. ^ PubChem. "Cannabichromevarin". pubchem.ncbi.nlm.nih.gov. U.S. National Library of Medicine, National Institutes of Health. Retrieved 2019-12-23.
  3. ^ "United States Patent: 9084771 - Methods and compositions for treating cancer".
  4. ^ "Cannabichromevarin".
  5. ^ "What is Cannabichromevarin - CBCV? | Ionization Labs".
  6. ^ http://patft.uspto.gov/netacgi/nph-Parser?d=PALL&p=1&u=%2Fnetahtml%2FPTO%2Fsrchnum.htm&r=1&f=G&l=50&s1=9084771.PN.&OS=PN/9084771&RS=PN/9084771